Mohammad Alkhalil

Feb 23, 2024 | heart.bmj.com | Valerie Josephine Dirjayanto |Mohammad Alkhalil |John A. Dodson |Gregory Mills

AbstractObjective This study aimed to explore the prognostic impact of cognitive impairment on the long-term risk of major adverse cardiovascular events (MACEs) in older patients with non-ST-elevation acute coronary syndrome (NSTEACS) undergoing invasive treatment. Methods Patients aged ≥75 years with NSTEACS undergoing an invasive strategy were included in the multicentre prospective study (NCT01933581).

Oct 9, 2023 | heart.bmj.com | Mohammad Alkhalil |John A. Dodson |Gregory Mills |Valerie Josephine Dirjayanto

AbstractObjective This study aimed to explore the prognostic impact of cognitive impairment on the long-term risk of major adverse cardiovascular events (MACEs) in older patients with non-ST-elevation acute coronary syndrome (NSTEACS) undergoing invasive treatment. Methods Patients aged ≥75 years with NSTEACS undergoing an invasive strategy were included in the multicentre prospective study (NCT01933581).

May 30, 2023 | mdpi.com | Ashish Gupta |Mohammad Alkhalil

Abstract:Omega-3 polyunsaturated fatty acids (PUFAs) were early established as therapeutic option for patients with high triglyceride levels. Their effects on lipoprotein particles, including a reduction in very low-density lipoprotein and a shift from small to large low-density lipoprotein, is increasingly recognised. This is coupled with their ability to be incorporated within the cellular membrane, leading to plaque stability and anti-inflammatory effects.